Navigation Links
Largest synthetic gene ever built offers insights into anti-malarial drug resistance

Researchers at Georgetown University Medical Center say they are moving closer to understanding why the most lethal form of human malaria has become resistant to drug treatment in the past three decades. They have been able to artificially construct, and then express in yeast, a protozoan gene that contributes to such resistance. And it was no small feat. The gene they laboriously constructed over a two-year period is believed to be the largest synthetic one ever built, and it successfully produces large quantities of the encoded protein, whose function can now be easily studied.

In research published in the May 22 issue of the journal Biochemistry, the researchers say that with the addition of the recreated gene, PfMDR1 and its protein, they have all the biomolecular tools necessary to molecularly understand how the malarial parasite Plasmodium falciparum (P. falciparum), has become resistant to most of the drugs that could once destroy it. They have already described and expressed two other genes known to confer drug resistance.

"Now that we have these genes expressed in a convenient yeast system, we can work to understand the molecular basis of anti-malarial drug resistance, providing insight into how future drugs might be designed to effectively kill the parasite," said Paul Roepe, Ph.D., a professor in the Department of Biochemistry and Cellular & Molecular Biology as well as the Department of Chemistry.

Any animal with red blood cells can develop malaria, which is caused by a single-cell protozoan parasite transmitted by the bite of the female Anopheles mosquito. There are about 160 different species of malaria parasites, according to Roepe. Five infect humans, but P. falciparum is responsible for about 1 million deaths out of 300 million acute cases of infection each year. Most of these deaths occur in young children living in sub-Saharan Africa.

Roepe and his collaborators at Georgetown University, in collaborat
'"/>

Source:Georgetown University Medical Center


Page: 1 2 3 4

Related biology news :

1. Largest computational biology simulation mimics life’s most essential nanomachine
2. Largest study of human interactome reveals a novel way
3. Largest genomic search finds genes that may contribute to autism
4. Inexpensive, mass-produced genes core of synthetic biology advances at UH
5. Researchers find promising cancer-fighting power of synthetic cell-signaling molecule
6. Tagging pathogens with synthetic DNA barcodes
7. Breakthrough in micro-device fabrication combines biology and synthetic chemistry
8. Heparin prepared synthetically could replace animal-derived drug
9. Williams College biologist explores photosynthetic apparatus
10. New synthetic self-assembling macromolecules mimic nature
11. Locusts built-in surface analysis ability directs them to fly overland

Post Your Comments:
(Date:11/20/2009)...Mass., November 19, 2009 The estimated 4.6 millio... at risk of developing respiratory symptoms due to...uestionnaire study undertaken earlier this year by...ol of Veterinary Medicine. , The studywhich poll...d that 50 percent of individuals working in barns ...
(Date:11/20/2009)...s available in German . , In the current on...on , Dr. Stefanie Eyerich and Dr. Kilian Eyerich t...e London and Istituto Dermopatico dell,Immacolata ...t represents a milestone on the way to developing ...es such as psoriasis and allergic reactions and po...
(Date:11/20/2009)... In a new study, researchers report that a class ... a helpful, or harmful, effect on the heart, depen...hich appears in the journal Circulation Research ...pha- and beta-receptors on the heart muscle offer ...that target only the beta-receptors can actually u...
Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2Carvedilol shown to have unique characteristics among beta blockers 2BCBSNC Promotes Seasonal Flu Shots and Waives Cost to Customers for H1N1 Vaccine 58842 1BCBSNC Promotes Seasonal Flu Shots and Waives Cost to Customers for H1N1 Vaccine 58842 2BCBSNC Promotes Seasonal Flu Shots and Waives Cost to Customers for H1N1 Vaccine 58842 3BCBSNC Promotes Seasonal Flu Shots and Waives Cost to Customers for H1N1 Vaccine 58842 4The Japanese Cancer Association and Debiopharm Group Present the JCA Mauvernay Award to Dr Ushijima for his Oncology Research 5204 1The Japanese Cancer Association and Debiopharm Group Present the JCA Mauvernay Award to Dr Ushijima for his Oncology Research 5204 2The Japanese Cancer Association and Debiopharm Group Present the JCA Mauvernay Award to Dr Ushijima for his Oncology Research 5204 3Environmental 26amp 3B Economic Factors Drives Global Demand for Pharmaceutical leak Testing and Deblistering 14346 1Environmental 26amp 3B Economic Factors Drives Global Demand for Pharmaceutical leak Testing and Deblistering 14346 2Environmental 26amp 3B Economic Factors Drives Global Demand for Pharmaceutical leak Testing and Deblistering 14346 3
...cation (BCA) technology, researchers analyzing flu...cted a protein linked in recent studies to Alzheim...e about the bio-bar-code technology : , - Gold n... detection ,- Nanoparticle-Based Bio–Bar Codes f...io-Barcode Diagnostic Method Could Rival PCR , ,...
...he causes for symptoms of sickle cell disease, a c...ans, has resulted from a study by researchers at D...dical Institute (HHMI). Their findings may lead to...e, they said. , Their research suggests that an i... through the release of nitric oxide is a major fa...
...rmidis is harmless on human skin, but it is the le...fections of indwelling medical devices. S. epiderm...ctions in people with prosthetic joints, replaceme...tibiotic resistance makes it tough to battle. More...omes so pathogenic once the protective barrier of ...
Other Biology News:Nanoscale Diagnostic Sets Sights on Alzheimer's 2Nanoscale Diagnostic Sets Sights on Alzheimer's 3Discovery Promises Simpler Therapy for Sickle Cell Disease 2Discovery Promises Simpler Therapy for Sickle Cell Disease 3
(Date:11/20/2009)... Spain and Latin American countries have an oppor... sectors. Researchers from the University of Valen...tion, have studied the productive fabric of the Sp...that Spain,s food and plant sectors have more clou...otechnology as applied to food and plants has been...
(Date:11/20/2009)..., , ROCKVILLE, Md., Nov. 20 /PRNewswire-F...announced that it has priced an underwritten publi... at a price to the public of $3.30 per share. The...deducting the underwriting discounts and commissio...cal trials of our VLP-based vaccines, internal res...
(Date:11/20/2009)... METTLER TOLEDO recently ...ctions Process Optimization Using At-Line Particle...ember 2, 2009. In this webinar, the application o...d to map the design space and optimize a series of...s, flow rates, and roller compaction forces. , ...
(Date:11/19/2009)..., , COPENHAGEN, Nov. 19 Dani...Inbicon cellulosic ethanol plant in Kalundborg, De...one of the world,s first and largest 2nd generatio...Accellerase enzymes are used in the plant,s innova...r, a Division of Danisco, was the first to market ...
Breaking Biology Technology:Spanish biotechnology should focus on food and plant sectors to be more competitive 2Novavax Prices Public Offering of Common Stock 2Roller Compaction Process Optimization Using At-Line Particle Characterization 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2
...t Nasdaq On November 14th, CARLSBAD, Calif., Nov....rvices provider, today announced it has been,ranke...00, a ranking of the,500 fastest-growing technolog...panies in North America. Rankings are based on the...e years, from 2003-2007. Genoptix grew 28,288,perc...
...lik, Inc.,(Nasdaq: TELK ) announced today an agre...logy to investigators at the Hospital for Special ...s the mechanisms underlying,musculoskeletal and au...,for these disorders. HSS investigators will use T... that inhibit a key enzyme in cell signaling and,m...
...mber 12 Shire,plc (LSE: SHP, NASDAQ: SHPGY), the ...ding an update on its Human Genetic Therapies (HGT...mber 2008., The seminar will include both an over...th look at the portfolio of HGT products both on t...rt at 9.00am (ET) and will,finish at 2.30pm (ET). ...
Other Biology Technology:Genoptix Ranked Ninth Fastest-Growing Company in North America on Deloitte's 2008 Technology Fast 500 2Genoptix Ranked Ninth Fastest-Growing Company in North America on Deloitte's 2008 Technology Fast 500 3Genoptix Ranked Ninth Fastest-Growing Company in North America on Deloitte's 2008 Technology Fast 500 4Telik Announces New TRAP Drug Discovery Agreement 2Confirmation of HGT Business Day - 18th November 2008 2
Goat Anti-cystatin A (N-18) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Human Cystatin A Monoclonal Antibody, Unconjugated, Clone 224705 from R&D Systems
Bcl I (HC) from Promega
...ezers , Ultima II Series ,Developed for ...esents the finest, most enhanced ultra-low freezer...bank configurations, each Ultima II freezer includ...em with built-in voltage boost and surge suppresso...
Biology Products: